What is the main treatment for ITP (Immune Thrombocytopenia)?

The main treatment for Immune Thrombocytopenia (ITP) focuses on managing the underlying autoimmune response that leads to low platelet counts. In this context, corticosteroids are commonly used as they help to reduce the immune system's attack on platelets, thereby increasing their count. Corticosteroids can decrease the production of antibodies that erroneously target platelets, offering symptomatic relief and improving platelet levels.

When corticosteroids are not effective or if the patient has severe, persistent thrombocytopenia, splenectomy (the surgical removal of the spleen) is often considered. The spleen plays a critical role in the breakdown of platelets and, by removing it, the destruction of platelets can be reduced, leading to an increase in platelet counts.

In contrast, blood transfusions, antibiotics, and platelet infusions do not address the root cause of ITP. Blood transfusions are primarily used in acute cases of severe bleeding but do not provide a long-term solution for low platelet counts. Antibiotics are used to treat infections, which are not the underlying issue in ITP. Platelet infusions may temporarily raise platelet counts, but like blood transfusions, they do not provide a lasting resolution to the condition and are not effective